Sales & Marketing The doctors have spoken: what physicians need from pharma co... In the rapidly changing field of medicine, effective communications are essential to ensuring that innovations are cascaded out across the health system.
Sales & Marketing Achieving launch excellence in oncology Any new drug launch must overcome numerous obstacles in the pursuit of success.
Sales & Marketing Unlocking the potential of connected commercialisation solut... It is no secret that today’s post-pandemic healthcare landscape in the UK is very different to its pre-pandemic counterpart.
Oncology Immunotherapy: building the fourth pillar of cancer treatmen... Cancer treatment has been traditionally characterised by surgery, chemotherapy, and radiation.
Oncology Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ... Researchers also dove into socio-economic disparities in cancer care.
Oncology New horizons in breast cancer care Interview with Markus Kosch, Daiichi Sankyo head of Oncology Business Division in Europe.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.